• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用液相色谱-串联质谱法测定小鼠血浆中的ulixertinib及其在小鼠药代动力学研究中的应用。

Determination of ulixertinib in mice plasma by LC-MS/MS and its application to a pharmacokinetic study in mice.

作者信息

Kumar Rajinish, Suresh P S, Rudresh G, Zainuddin Mohd, Dewang Purushottam, Kethiri Ragahava Reddy, Rajagopal Sriram, Mullangi Ramesh

机构信息

Jubilant Biosys Ltd., Industrial Suburb, Yeshwanthpur, Bangalore 560 022, India.

Medicinal Chemistry, Jubilant Biosys Ltd., Industrial Suburb, Yeshwanthpur, Bangalore 560 022, India.

出版信息

J Pharm Biomed Anal. 2016 Jun 5;125:140-4. doi: 10.1016/j.jpba.2016.03.036. Epub 2016 Mar 17.

DOI:10.1016/j.jpba.2016.03.036
PMID:27017572
Abstract

A sensitive, specific and rapid LC-ESI-MS/MS method has been developed and validated for the quantification of ulixertinib in mice plasma using phenacetin as an internal standard (I.S.) as per regulatory guidelines. Sample preparation was accomplished through a protein precipitation procedure with acetonitrile:methanol mixture. Chromatographic separation was performed on Atlantis dC18 column using a binary gradient using mobile phase A (0.2% formic acid in water) and B (acetonitrile) at a flow rate of 0.60mL/min. Elution of ulixertinib and I.S. occurred at ∼1.07 and 1.20min, respectively. The total chromatographic run time was 2.5min. A linear response function was established in the concentration range of 1.58-2054ng/mL. The intra- and inter-day accuracy and precisions were in the range of 2.11-11.8 and 5.80-11.4%, respectively. This novel method has been applied to a pharmacokinetic study in mice.

摘要

根据监管指南,已开发并验证了一种灵敏、特异且快速的液相色谱-电喷雾串联质谱(LC-ESI-MS/MS)方法,用于以非那西丁作为内标(I.S.)对小鼠血浆中的乌利西替尼进行定量分析。样品制备通过用乙腈:甲醇混合物进行蛋白沉淀程序来完成。色谱分离在Atlantis dC18柱上进行,使用二元梯度,流动相A(0.2%甲酸水溶液)和B(乙腈),流速为0.60mL/min。乌利西替尼和内标的洗脱时间分别约为1.07分钟和1.20分钟。总色谱运行时间为2.5分钟。在1.58 - 2054ng/mL的浓度范围内建立了线性响应函数。日内和日间准确度及精密度分别在2.11 - 11.8%和5.80 - 11.4%的范围内。这种新方法已应用于小鼠的药代动力学研究。

相似文献

1
Determination of ulixertinib in mice plasma by LC-MS/MS and its application to a pharmacokinetic study in mice.采用液相色谱-串联质谱法测定小鼠血浆中的ulixertinib及其在小鼠药代动力学研究中的应用。
J Pharm Biomed Anal. 2016 Jun 5;125:140-4. doi: 10.1016/j.jpba.2016.03.036. Epub 2016 Mar 17.
2
Sensitive method for the determination of rocilinostat in small volume mouse plasma by LC-MS/MS and its application to a pharmacokinetic study in mice.采用液相色谱-串联质谱法测定小鼠小体积血浆中罗西他司他的灵敏方法及其在小鼠药代动力学研究中的应用。
Biomed Chromatogr. 2016 Jul;30(7):1138-1144. doi: 10.1002/bmc.3665. Epub 2016 Jan 14.
3
Validation of an LC-ESI-MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice.建立 LC-ESI-MS/MS 法测定小鼠血浆中新型非甾体类抗雄激素阿帕鲁胺的浓度及其在小鼠药代动力学研究中的应用。
J Pharm Biomed Anal. 2018 May 10;153:260-266. doi: 10.1016/j.jpba.2018.02.054. Epub 2018 Feb 27.
4
LC-MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice.LC-MS/MS 测定新型 GSK-3β 抑制剂 tideglusib 在小鼠血浆中的浓度及其在小鼠药代动力学研究中的应用。
J Pharm Biomed Anal. 2018 Jan 30;148:100-107. doi: 10.1016/j.jpba.2017.09.022. Epub 2017 Sep 23.
5
LC-ESI-MS/MS determination of 4-methylpyrazole in dog plasma and its application to a pharmacokinetic study in dogs.液相色谱-电喷雾串联质谱法测定犬血浆中4-甲基吡唑及其在犬体内的药代动力学研究中的应用。
Biomed Chromatogr. 2018 Feb;32(2). doi: 10.1002/bmc.4065. Epub 2017 Sep 25.
6
LC-ESI-MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice.LC-ESI-MS/MS 法测定新型 FAK 抑制剂 defactinib 在小鼠血浆中的浓度及其在小鼠药代动力学研究中的应用。
J Pharm Biomed Anal. 2018 Feb 5;149:358-364. doi: 10.1016/j.jpba.2017.11.022. Epub 2017 Nov 10.
7
Quantitative analysis of enasidenib in dried blood spots of mouse blood using an increased-sensitivity LC-MS/MS method: Application to a pharmacokinetic study.使用提高灵敏度的液相色谱-串联质谱法对小鼠血液干血斑中的恩杂鲁胺进行定量分析:在药代动力学研究中的应用。
Biomed Chromatogr. 2019 Jun;33(6):e4491. doi: 10.1002/bmc.4491. Epub 2019 Feb 7.
8
Sensitive LC-MS/MS Method for the Simultaneous Determination of Bendamustine and its Active Metabolite, γ-Hydroxybendamustine in Small Volume Mice and Dog Plasma and its Application to a Pharmacokinetic Study in Mice and Dogs.用于同时测定小体积小鼠和犬血浆中苯达莫司汀及其活性代谢物γ-羟基苯达莫司汀的灵敏液相色谱-串联质谱法及其在小鼠和犬药代动力学研究中的应用
Drug Res (Stuttg). 2017 Sep;67(9):497-508. doi: 10.1055/s-0043-108124. Epub 2017 May 30.
9
Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC-MS/MS and its application to a pharmacokinetic study in mice.通过液相色谱-串联质谱法测定小鼠血浆中新型吲哚胺2,3-双加氧酶1(IDO1)抑制剂依帕卡托,并将其应用于小鼠药代动力学研究。
Biomed Chromatogr. 2017 Feb;31(2). doi: 10.1002/bmc.3794. Epub 2016 Aug 11.
10
Highly sensitive method for the determination of adenosine by LC-MS/MS-ESI: method validation and scope of application to a pharmacokinetic/pharmacodynamic study.采用液相色谱-串联质谱联用-电喷雾电离法测定腺苷的高灵敏度方法:方法验证及在药代动力学/药效学研究中的应用范围
Biomed Chromatogr. 2012 Jan;26(1):81-8. doi: 10.1002/bmc.1629. Epub 2011 Apr 13.

引用本文的文献

1
High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer.高通量功能评估 MAP2K1 变体在癌症中的作用。
Mol Cancer Ther. 2023 Feb 1;22(2):227-239. doi: 10.1158/1535-7163.MCT-22-0302.
2
ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.ASN007 是一种选择性 ERK1/2 抑制剂,对 RAS 和 RAF 突变型肿瘤具有优先活性。
Cell Rep Med. 2021 Jul 21;2(7):100350. doi: 10.1016/j.xcrm.2021.100350. eCollection 2021 Jul 20.
3
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer.
解析人结直肠癌中靶向药物联合治疗耐药的机制。
Oncogene. 2019 Jun;38(25):5076-5090. doi: 10.1038/s41388-019-0780-z. Epub 2019 Mar 25.
4
Pharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MS.采用超高效液相色谱-串联质谱法对ICR小鼠中土贝母苷甲的药代动力学和生物利用度研究
J Anal Methods Chem. 2018 Jul 5;2018:9074893. doi: 10.1155/2018/9074893. eCollection 2018.
5
Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics.新型ERK1/2抑制剂乌利司他尼在小鼠、大鼠和犬体内药代动力学对人体药代动力学的预测
Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):453-460. doi: 10.1007/s13318-018-0465-y.